What does CUSIP M47238122 represent in this 13F holders report?

CUSIP M47238122 is the security identifier for GLMD - GALMED PHARMACEUTICALS LTD - SHS NEW used to aggregate holder disclosures.

How many institutions held GLMD - GALMED PHARMACEUTICALS LTD - SHS NEW in Q3 2024?

No institutional holders were reported for GLMD - GALMED PHARMACEUTICALS LTD - SHS NEW in Q3 2024; review adjacent reporting periods for trend context.

GALMED PHARMACEUTICALS LTD - SHS NEW (GLMD)

CUSIP: M47238122

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class: Equity / SHS NEW
Total 13F shares: 0
Share change: -349,492
Total reported value: $0
Number of holders: 0
Value change: -$99,436
Number of sells: 10

Quarterly Holders Quick Answers

What is CUSIP M47238122?
CUSIP M47238122 identifies GLMD - GALMED PHARMACEUTICALS LTD - SHS NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q2 2024

Recent filing periods for CUSIP M47238122:

Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023

GALMED PHARMACEUTICALS LTD - SHS NEW (GLMD)

Q3 2024 13F Holders as of 30 Sep 2024

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of GLMD - GALMED PHARMACEUTICALS LTD - SHS NEW as of Q3 2024.